Funder: Takeda Pharmaceuticals
Due Dates (Anticipated): June 2026
Funding Amounts: Typical award size and duration not specified; funding varies by project and scope.
Summary: Supports independent, evidence-based medical education to advance clinical knowledge and improve patient care in oncology and related fields.